Apex Biotechnology Corp.

TWSE:1733 Lagerbericht

Marktkapitalisierung: NT$2.9b

Apex Biotechnology Management

Management Kriterienprüfungen 1/4

We currently do not have sufficient information about the CEO.

Wichtige Informationen

Thomas Y. Shen

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführers10.4%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder6.8yrs

Jüngste Management Updates

Recent updates

Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Aug 06
Apex Biotechnology (TWSE:1733) Will Be Hoping To Turn Its Returns On Capital Around

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Apr 17
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Mar 30
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Mar 10
Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

Feb 17
Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Jan 27
A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

Jan 06
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Dec 16
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Nov 22
Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Geschäftsführer

Thomas Y. Shen

no data

Amtszeit

Dr. Thomas Y. S. Shen, Ph D serves as Chairman, Chief Executive Officer and General Manager of Apex Biotechnology Corp. Dr. Shen served as Supervisor/Corporate Representative at Sheng Da Venture Capital. D...

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Thomas Y. Shen
Chairmanno datakeine Daten10.38%
NT$ 301.4m
Meng Yang
Vice GMno datakeine Daten0.28%
NT$ 8.2m
Yung-Luh Tsaih
Independent Director3.3yrskeine Datenkeine Daten
I-Tan Chih
Independent Directorno datakeine Datenkeine Daten
Pai Ming
Independent Director6.8yrskeine Datenkeine Daten
Jin-Chang Bou
Independent Director6.8yrskeine Datenkeine Daten

6.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: 1733's board of directors are considered experienced (6.8 years average tenure).